Oxidative stress and growth-regulating intracellular signaling pathways in cardiac myocytes

Antioxidants and Redox Signaling

Volumn 8, Issue 11-12, 2006, Pages 2111-2124

  Sugden, Peter H ^a   Clerk, Angela ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUROHORMONE; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE C; RAS PROTEIN; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE;

CELL GROWTH; DEPHOSPHORYLATION; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME INACTIVATION; ENZYME INHIBITION; HEART MUSCLE CELL; HUMAN; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION; ANIMAL; METABOLISM; PHYSIOLOGY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL GROWTH PROCESSES; HUMANS; MAP KINASE SIGNALING SYSTEM; MYOCYTES, CARDIAC; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 33947689707     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2006.8.2111     Document Type: Review

References (154)

1. Abe J, Kusuhara M, Ulevitch RJ, Berk BC, and Lee J-D. Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase. J Biol Chem 271: 16586-16590, 1996.
2. Adachi T, Pimentel DR, Heibeck T, Hou X, Lee YJ, Jiang B, Ido Y, and Cohen RA. S-glutathiolation of Ras mediates redox-sensitive signaling by angiotensin II in vascular smooth muscle cells. J Biol Chem 279: 29857-29862, 2004.
3. Aikawa R, Komuro I, Yamazaki T, Zou Y, Kudoh S, Tanaka M, Shiojima I, Hiroi Y, and Yazaki Y. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J Clin Invest 100: 1813-1821, 1997.
4. Amin JK, Xiao L, Pimental DR, Pagano PJ, Singh K, Sawyer DB, and Colucci WS. Reactive oxygen species mediate alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. J Mol Cell Cardiol 33: 131-139, 2001.
5. Andreka P, Zang J, Dougherty C, Slepak TI, Webster KA, and Bishopric NH. Cytoprotection by Jun kinase during nitric oxide-induced cardiac myocyte apoptosis. Circ Res 88: 305-312, 2001.
6. Aoki H, Izumo S, and Sadoshima J. Angiotensin II activates RhoA in cardiac myocytes: a critical role of RhoA in angiotensin II-induced premyofibril formation. Circ Res 82: 666-676, 1998.
7. Baines CP and Molkentin JD. STRESS signaling pathways that modulate cardiac myocyte apoptosis. J Mol Cell Cardiol 38: 47-62, 2005.
8. Ballinger SW. Mitochondrial dysfunction in cardiovascular disease. Free Radic Biol Med 38: 1278-1295, 2005.
9. Barford D. The role of cysteine residues as redox-sensitive regulatory switches. Curr Opin Struct Biol 14: 679-686, 2004.
10. Bayascas JR and Alessi DR. Regulation of Akt/PKB Ser473 phosphorylation. Mol Cell 18: 143-145, 2005.
11. Bergo MO, Lieu HD, Gavino BJ, Ambroziak P, Otto JC, Casey PJ, Walker QM, and Young SG. On the physiological importance of endoproteolysis of CAAX proteins: heart-specific RCE1 knockout mice develop a lethal cardiomyopathy. J Biol Chem 279: 4729-4736, 2004.
12. Berthiaume LG. Insider information: how palmitoylation of Ras makes it a signaling double agent. Sci STKE 2002: PE41, 2002.
13. Bevan AP, Drake PG, Yale JF, Shaver A, and Posner BI. Peroxovanadium compounds: biological actions and mechanism of insulin-mimesis. Mol Cell Biochem 153: 49-58, 1995.
14. Bogoyevitch MA, and Court NW. Counting on mitogen-activated protein kinases-ERKs 3, 4, 5, 6, 7 and 8. Cell Signal 16: 1345-1354, 2004.
15. Bogoyevitch MA, Gillespie-Brown J, Ketterman AJ, Fuller SJ, Ben-Levy R, Ashworth A, Marshall CJ, and Sugden PH. Stimulation of the stress-activated mitogen-activated protein kinases subfamilies in perfused heart. p38/RK mitogen-activated kinases and c-Jun N-terminal kinases are activated by ischemia-reperfusion. Circ Res 79: 161-173, 1996.
16. Bogoyevitch MA, Glennon PE, Andersson MB, Clerk A, Lazou A, Marshall CJ, Parker PJ, and Sugden PH. Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy. J Biol Chem 269: 1110-1119, 1994.
17. Bogoyevitch MA, Glennon PE, and Sugden PH. Endothelin-1, phorbol esters and phenylephrine stimulate MAP kinase activities in ventricular cardiomyocytes. FEBS Lett 317: 271-275, 1993.
18. Bogoyevitch MA, Ketterman AJ, and Sugden PH. Cellular stresses differentially activate c-Jun N-terminal protein kinases and extracellular signal-regulated protein kinases in cultured ventricular myocytes. J Biol Chem 270: 29710-29717, 1995.
19. Bogoyevitch MA, Marshall CJ, and Sugden PH. Hypertrophic agonists stimulate the activities of the protein kinases c-Raf and A-Raf in cultured ventricular myocytes. J Biol Chem 270: 26303-26310, 1995.
20. Bogoyevitch MA, Ng DCH, Court NW, Draper KA, Dhillon A, and Abas L. Intact mitochondrial electron transport function is essential for signaling by hydrogen peroxide in cardiac myocytes. J Mol Cell Cardiol 32: 1469-1480, 2000.
21. Bogumil R, Namgaladze D, Schaarschmidt D, Schmachtel T, Hellstern S, Mutzel R, and Ullrich V. Inactivation of calcineurin by hydrogen peroxide and phenylarsine oxide. Evidence for a dithiol-disulfide equilibrium and implications for redox regulation. Eur J Biochem 267: 1407-1415, 2000.
22. Brazil DP and Hemmings BA. Ten years of protein kinase B signaling: a hard Akt to follow. Trends Biochem Sci 26: 657-664, 2001.
23. Brazil DP, Yang ZZ, and Hemmings BA. Advances in protein kinase B signaling: AKTion on multiple fronts. Trends Biochem Sci 29: 233-242, 2004.
24. Brodie C and Blumberg PM. Regulation of cell apoptosis by protein kinase c δ. Apoptosis 8: 19-27, 2003.
25. Bueno OF, De Windt LJ, Tymitz KM, Witt SA, Kimball TR, Klevitsky R, Hewett TE, Jones SP, Lefer DJ, Peng C-F, Kitsis RN, and Molkentin JD. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J 19: 6341-6350, 2000.
26. Bueno OF and Molkentin JD. Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ Res 91: 776-781, 2002.
27. Chen CH, Cheng TH, Lin H, Shih NL, Chen YL, Chen YS, Cheng CF, Lian WS, Meng TC, Chiu WT, and Chen JJ. Reactive oxygen species generation is involved in epidermal growth factor receptor transactivation through the transient oxidization of Src homology 2-containing tyrosine phosphatase in endothelin-1 signaling pathway in rat cardiac fibroblasts. Mol Pharmacol 69: 1347-1355, 2006.
28. Chen QM, Tu VC, Wu Y, and Bahl JJ. Hydrogen peroxide dose dependent induction of cell death or hypertrophy in cardiac myocytes. Arch Biochem Biophys 373: 242-248, 2000.
29. Chen Z, Gibson TB, Robinson F, Silvestro L, Pearson G, Xu B, Wright A, Vanderbilt C, and Cobb MH. MAP kinases. Chem Rev 101: 2449-2476, 2001.
30. Cheng T-H, Cheng P-Y, Shih N-L, Chen I-B, Wang DL, and Chen J-J. Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts. J Am Coll Cardiol 42: 1845-1854, 2003.
31. Cheng TH, Shih NL, Chen SY, Wang DL, and Chen JJ. Reactive oxygen species modulate endothelin-1-induced c-fos gene expression in cardiomyocytes. Cardiovasc Res 41: 654-662, 1999.
32. Chiloeches A, Paterson HF, Marais R, Clerk A, Marshall CJ, and Sugden PH. Regulation of Ras.GTP loading and Ras-Raf association in neonatal rat ventricular myocytes by G protein-coupled receptor agonists and phorbol ester. Activation of the ERK cascade by phorbol ester is mediated by Ras. J Biol Chem 274: 19762-19770, 1999.
33. Chong Y-P, Mulhern TD, and Cheng H-C. C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)-endogenous negative regulators of Src-family protein kinases. Growth Factors 23: 233-244, 2005.
34. Chu F, Ward NE, and O'Brian CA. PKC isozyme S-cysteinylation by cystine stimulates the pro-apoptotic isozyme PKCδ and inactivates the oncogenic isozyme PKCε. Carcinogenesis 24: 317-325, 2003.
35. Cicchilliti L, Fasanaro P, Biglioli P, Capogrossi MC, and Martelli F. Oxidative stress induces protein phosphatase 2A-dependent dephosphorylation of the pocket proteins pRb, p107, and p130. J Biol Chem 278: 19509-19517, 2003.
36. Clavreul N, Adachi T, Pimental DR, Ido Y, Schöneich C, and Cohen RA. S-glutathiolation by peroxynitrite of p21ras at cysteine-118 mediates its direct activation and downstream signaling in endothelial cells. FASEB J 20: 518-520, 2006.
37. Clerk A, Aggeli I-K, Stathopoulou K, and Sugden PH. Peptide growth factors signal differentially through protein kinase C to extracellular signal-regulated kinase in neonatal cardiomyocytes. Cell Signal 18: 225-235, 2006.
38. Clerk A, Bogoyevitch MA, Andersson MB, and Sugden PH. Differential activation of protein kinase C isoforms by endothelin-1 and phenylephrine and subsequent stimulation of p42 and p44 mitogen-activated protein kinases in ventricular myocytes cultured from neonatal rat hearts. J Biol Chem 269: 32848-32857, 1994.
39. Clerk A, Bogoyevitch MA, Fuller SJ, Lazou A, Parker PJ, and Sugden PH. Expression of protein kinase C isoforms during cardiac ventricular development. Am J Physiol 269: H1087-H1097, 1995.
40. Clerk A, Fuller SJ, Michael A, and Sugden PH. Stimulation of "stress-regulated" mitogen-activated protein kinases (stress-activated protein kinases/c-Jun N-terminal kinases and p38-mitogen-activated protein kinases) by oxidative and other stresses. J Biol Chem 273: 7228-7234, 1998.
41. Clerk A, Michael A, and Sugden PH. Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine: a role in cardiac myocyte hypertrophy? J Cell Biol 142: 523-535, 1998.
42. Clerk A, Michael A, and Sugden PH. Stimulation of multiple mitogen-activated protein kinase sub-families by oxidative stress and phosphorylation of the small heat shock protein, HSP25/27, in neonatal ventricular myocytes. Biochem J 333: 581-589, 1998.
43. Clerk A, Pham FH, Fuller SJ, Sahai E, Aktories K, Marais R, Marshall CJ, and Sugden PH. Regulation of mitogen-activated protein kinases in cardiac myocytes through the small G protein, Rac1. Mol Cell Biol 21: 1173-1184, 2001.
44. Clerk A and Sugden PH. Small guanine nucleotide-binding proteins and myocardial hypertrophy. Circ Res 86: 1019-1023, 2000.
45. Cohen P. The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends Cell Biol 7: 353-361, 1997.
46. Cohen P, Holmes CF, and Tsukitani Y. Okadaic acid: a new probe for the study of cellular regulation. Trends Biochem Sci 15: 98-102, 1990.
47. Cook SA, Sugden PH, and Clerk A. Regulation of Bcl-2 family proteins during development and in response to oxidative stress in cardiac myocytes: association with changes in mitochondrial membrane potential. Circ Res 85: 940-949, 1999.
48. Court NW, dos Remedies CG, Cordell J, and Bogoyevitch MA. Cardiac expression and subcellular localization of the p38 mitogen-activated protein kinase member, stress-activated protein kinase-3 (SAPK3). J Mol Cell Cardiol 34: 413-426, 2002.
49. de Rooij J and Bos JL. Minimal Ras binding domain of Raf1 can be used as an activation-specific probe for Ras. Oncogene 14: 623-625, 1997.
50. de Vos AM, Tong L, Milburn MV, Matias PM, Jancarik J, Noguchi S, Nishimura S, Miura K, Ohtsuka E, and Kim S-H. Three-dimensional structure on an oncogene protein: catalytic domain of human c-H-ras p21. Science 239: 888-893, 1988.
51. Dougherty CJ, Kubasiak LA, Prentice H, Andreka P, Bishopric NH, and Webster KA. Activation of c-Jun N-terminal kinase promotes survival of cardiac myocytes after oxidative stress. Biochem J 362: 561-571, 2002.
52. Farooq A and Zhou MM. Structure and regulation of MAPK phosphatases. Cell Signal 16: 769-779, 2004.
53. Feig LA and Cooper GM. Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol Cell Biol 8: 3235-3243, 1988.
54. 2 sensitivity of the major constitutive MAPK phosphatase from rat brain. Biochem Biophys Res Commun 315: 568-574, 2004.
55. Frey N and Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65: 45-79, 2003.
56. Ghezzi P. Regulation of protein function by glutathionylation. Free Radic Res 39: 573-580, 2005.
57. Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 115: 500-508, 2005.
58. Goldhaber JI and Liu E. Excitation-contraction coupling in single guinea-pig ventricular myocytes exposed to hydrogen peroxide. J Physiol 477: 135-147, 1994.
59. Griendling KK and Ushio-Fukai M. Redox control of vascular smooth muscle proliferation. J Lab Clin Med 132: 9-15, 1998.
60. Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, Dérijard B, and Davis RJ. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 15: 2760-2770, 1996.
61. Gutcher I, Webb PR, and Anderson NG. The isoform-specific regulation of apoptosis by protein kinase C. Cell Mol Life Sci 60: 1061-1070, 2003.
62. Hata-Tanaka A, Kawai G, Yamasaki K, Ito Y, Kajiura H, Ha JM, Miyazawa T, Yokoyama S, and Nishimura S. Spin-labeling proton NMR study on aromatic amino acid residues in the guanine nucleotide binding site of human c-Ha-ras(1-171) protein. Biochemistry 28: 9550-9556, 1989.
63. Hayashi M and Lee J-D. Role of the BMK1/ERK5 signaling pathway: lessons from knockout mice. J Mol Med 82: 800-808, 2004.
64. Heidkamp MC, Bayer AL, Martin JL, and Samarel AM. Differential activation of mitogen-activated protein kinase cascades and apoptosis by protein kinase Cε and δ in neonatal rat ventricular myocytes. Circ Res 89: 882-890, 2001.
65. Ras S-nitrosylation and kinetics of nitric oxide-mediated guanine nucleotide exchange. Biochemistry 43: 2314-2322, 2004.
66. Heo J and Campbell SL. Superoxide anion radical modulates the activity of Ras and Ras-related GTPases by a radical mechanism similar to that of nitric oxide. J Biol Chem 280: 12438-12435, 2005.
67. Heo J and Campbell SL. Mechanism of redox-mediated guanine nucleotide exchange on redox-active Rho GTPases. J Biol Chem 280: 31003-31010, 2005.
68. Heo J and Campbell SL. Ras regulation by reactive oxygen and nitrogen species. Biochemistry 45: 2200-2210, 2006.
69. Heo J, Prutzman KC, Mocanu V, and Campbell SL. Mechanism of free radical nitric oxide-mediated Ras guanine nucleotide dissociation. J Mol Biol 346: 1423-1440, 2005.
70. Hirotani S, Otsu K, Nishida K, Higuchi Y, Morita T, Nakayama H, Yamaguchi O, Mano T, Matsumura Y, Ueno H, Tada M, and Hori M. Involvement of nuclear factor-6B and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy. Circulation 105: 509-515, 2002.
71. 2-terminal kinase activation via a glutathione reductase-mediated mechanism. Circ Res 91: 712-718, 2002.
72. Hoshijima M, Sah VP, Wang Y, Chien KR, and Brown JH. The low molecular weight GTPase Rho regulates myofibril formation and organization in neonatal rat ventricular myocytes. Involvement of Rho kinase. J Biol Chem 273: 7725-7730, 1998.
73. Izumiya Y, Kim S, Izumi Y, Yoshida K, Yoshiyama M, Matsuzawa A, Ichijo H, and Iwao H. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin 11-induced cardiac hypertrophy and remodeling. Circ Res 93: 874-883, 2003.
74. Kabir AM, Cao X, Gorog DA, Tanno M, Bassi R, Bellahcene M, Quinlan RA, Davis RJ, Flavell RA, Shattock MJ, and Marber MS. Antimycin A induced cardioprotection is dependent on pre-ischemic p38-MAPK activation but is independent of MKK3. J Mol Cell Cardiol 39: 709-717, 2005.
75. Kanthasamy AG, Kitazawa M, Kanthasamy A, and Anantharam V. Role of proteolytic activation of protein kinase Cδ in oxidative stress-induced apoptosis. Antioxid Redox Signal 5: 609-620, 2003.
76. Kaul S, Anantharam V, Yang Y, Choi CJ, Kanthasamy A, and Kanthasamy AG. Tyrosine phosphorylation regulates the proteolytic activation of protein kinase Cδ in dopaminergic neuronal cells. J Biol Chem 280: 28721-28730, 2005.
77. Kennedy RA, Kemp TJ, Sugden PH, and Clerk A. Using U0126 to dissect the role of the extracellular signal-regulated kinase 1/2 (ERK1/2) cascade in the regulation of gene expression by endothelin-1 in cardiac myocytes. J Mol Cell Cardiol 41: 236-247, 2006.
78. Kirshenbaum LA, Thomas TP, Randhawa AK, and Singal PK. Time-course of cardiac myocyte injury due to oxidative stress. Mol Cell Biochem 111: 25-31, 1992.
79. Klebanoff SJ. Myeloperoxidase: friend and foe. J Leukoc Biol 77: 598-625, 2005.
80. 2. Proc Natl Acad Sci USA 94: 11233-11237, 1997.
81. 2-treated cells and its activation by tyrosine kinase in vitro. Proc Natl Acad Sci USA 98: 6587-6592, 2001.
82. Kumar S, McDonnell PC, Gum RJ, Hand AT, Lee JC, and Young PR. Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem Biophys Res Commun 235: 533-538, 1997.
83. Kuster GM, Pimentel DR, Adachi T, Ido Y, Brenner DA, Cohen RA, Liao R, Siwik DA, and Colucci WS. α-Adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes is mediated via thioredoxin-1-sensitive oxidation of thiols on Ras. Circulation 111: 1192-1198, 2005.
84. 2 regulates cardiac myocyte phenotype via concentration-dependent activation of distinct kinase pathways. J Mol Cell Cardiol 35: 615-621, 2003.
85. Kwon Y-W, Masutani H, Nakamura H, Ishii Y, and Yodoi J. Redox regulation of cell growth and cell death. Biol Chem 384: 991-996, 2003.
86. Kyaw M, Yoshizumi M, Tsuchiya K, Kirima K, and Tamaki T. Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells. Hypertens Res 24: 251-261, 2001.
87. Laderoute KR and Webster KA. Hypoxia/reoxygenation stimulates Jun kinase activity through redox signaling in cardiac myocytes. Circ Res 80: 336-344, 1997.
88. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4: 181-189, 2004.
89. ras interaction. J Biol Chem 272: 4323-4326, 1997.
90. Lazou A, Sugden PH, and Clerk A. Activation of mitogen-activated protein kinases (p38-MAPKs, SAPKs/JNKs and ERKs) by the G protein-coupled receptor agonist phenylephrine in the perfused rat heart. Biochem J 332: 459-465, 1998.
91. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys RJ, Landvatter SW, Strickler JE, McLaughlin MM, Siemens IR, Fisher SM, Livi GP, White JR, Adams JL, and Young PR. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372: 739-746, 1994.
92. Lemke LE, Bloem LJ, Fouts R, Esterman M, Sandusky G, and Vlahos CJ. Decreased p38 MAPK activity in end-stage failing human myocardium: p38 MAPK α is the predominant isoform expressed in human heart. J Mol Cell Cardiol 33: 1527-1540, 2001.
93. Ma XL, Kumar S, Gao F, Louden CS, Lopez BL, Christopher TA, Wang C, Lee JC, Feuerstein GZ, and Yue TL. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation 99: 1685-1691, 1999.
94. Matsui T and Rosenzweig A. Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of P1 3-kinase and Akt. J Mol Cell Cardiol 38: 63-71, 2005.
95. Maurer-Stroh S, Washietl S, and Eisenhaber F. Protein prenyl-transferases: anchor size, pseudogenes and parasites. Biol Chem 384: 977-989, 2003.
96. Mott HR, Carpenter JW, and Campbell SL. Structural and functional analysis of a mutant Ras protein that is insensitive to nitric oxide activation. Biochemistry 36: 3640-3644, 1997.
97. Murdoch CE, Grieve DJ, Cave AC, Looi YH, and Shah AM. NADPH oxidase and heart failure. Curr Opin Pharmacol 6: 148-153, 2006.
98. Murriel CL, Churchill E, Inagaki K, Szweda LI, and Mochly-Rosen D. Protein kinase Cδ activation induces apoptosis in response to cardiac ischemia and reperfusion damage: a mechanism involving BAD and the mitochondria. J Biol Chem 279: 47985-47991, 2004.
99. Nakamura K, Fushimi K, Kouchi H, Mihara K, Miyazaki M, Ohe T, and Namba M. Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-" and angiotensin II. Circulation 98: 794-799, 1998.
100. Newton AC. Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem Rev 101: 2353-2364, 2001.
101. Newton AC. Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem J 370: 361-371, 2003.
102. Nicol RL, Frey N, Pearson G, Cobb M, Richardson J, and Olson EN. Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO J 20: 2757-2767, 2001.
103. O'Brian CA and Chu F. Post-translational disulfide modifications in cell signaling-role of inter-protein, intra-protein, S-glutathionyl, and S-cystaminyl disulfide modifications in signal transmission. Free Radic Res 39: 471-480, 2005.
104. O'Loghlen A, Perez-Morgado MI, Salinas M, and Martin ME. Reversible inhibition of the protein phosphatase 1 by hydrogen peroxide. Potential regulation of eIF2α phosphorylation in differentiated PC-12 cells. Arch Biochem Biophys 417: 194-202, 2003.
105. Olson EN and Schneider MD. Sizing up the heart: development redux in disease. Genes Dev 17: 1937-1956, 2003.
106. Opie LH, Commerford PJ, Gersh BJ, and Pfeffer MA. Controversies in ventricular remodelling. Lancet 367: 356-367, 2006.
107. Parker PJ and Murray-Rust J. PKC at a glance. J Cell Sci 117: 131-132, 2004.
108. Passi S, Picardo M, Mingrone G, Breathnach AS, and Nazzaro-Porro M. Azelaic acid: biochemistry and metabolism. Acta Derm Venereol Suppl (Stockh) 143: 8-13, 1989.
109. Perez-Pinzon MA, Dave KR, and Raval AP. Role of reactive oxygen species and protein kinase C in ischemic tolerance in the brain. Antioxid Redox Signal 7: 1150-1157, 2005.
110. Pham FH, Sugden PH, and Clerk A. Regulation of protein kinase B and 4E-BP1 by oxidative stress in cardiac myocytes. Circ Res 86: 1252-1258, 2000.
111. Pimentel DR, Amin JK, Xiao L, Miller T, Viereck J, Oliver-Krasinski J, Baliga R, Wang J, Siwik DA, Singh K, Pagano P, Colucci WS, and Sawyer DB. Reactive oxygen species mediate amplitude-dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes. Circ Res 89: 453-460, 2001.
112. Rao GN. Hydrogen peroxide induces complex formation of SHC-Grb2-SOS with receptor tyrosine kinase and activates Ras and extracellular signal-regulated protein kinase group of mitogen-activated protein kinases. Oncogene 13: 713-719, 1996.
113. Rao RK and Clayton LW. Regulation of protein phosphatase 2A by hydrogen peroxide and glutathiolation. Biochem Biophys Res Commun 293: 610-616, 2002.
114. Raval AP, Dave KR, Prado R, Katz LM, Busto R, Sick TJ, Ginsberg MD, Mochly-Rosen D, and Pérez-Pinzón MA. Protein kinase C delta cleavage initiates and aberrant signal transduction pathway after cardiac arrest and oxygen glucose deprivation. J Cereb Blood Flow Metab 25: 730-741, 2005.
115. Rhee SG, Bae YS, Lee SR, and Kwon J. Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Sci STKE 2000: PE1: 2000.
116. Rhee SG, Chae HZ, and Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 38: 1543-1552, 2005.
117. Rhee SG, Kang SW, Jeong W, Chang T-S, Yang K-S, and Woo HA. Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr Opin Cell Biol 17: 183-189, 2005.
118. Roskoski R, Jr. Src protein-tyrosine kinase structure and regulation. Biochem Biophys Res Commun 324: 1155-1164, 2004.
119. Rybin VO, Guo J, Sabri A, Elouardighi H, Schaefer E, and Steinberg SF. Stimulus-specific differences in protein kinase Cδ localization and activation mechanisms in cardiomyocytes. J Biol Chem 279: 19350-19361, 2004.
120. + exchange in neonatal rat cardiac myocytes. Circ Res 82: 1053-1062, 1998.
121. Sadoshima J and Izumo S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol 59: 551-571, 1997.
122. Salmeen A and Barford D. Functions and mechanisms of redox regulation of cysteine-based phosphatases. Antioxid Redox Signal 7: 560-577, 2005.
123. Sanz V, Arozarena I, and Crespo P. Distinct carboxy-termini confer divergent characteristics to the mitogen-activated protein kinase p38α and its splice isoform Mxi2. FEBS Lett 474: 169-174, 2000.
124. Saurin AT, Martin JL, Heads RJ, Foley C, Mockridge JW, Wright MJ, Wang Y, and Marber MS. The role of differential activation of p38-mitogen-activated protein kinase in preconditioned ventricular myocytes. FASEB J 14: 2237-2246, 2000.
125. Sawyer DB, Siwik DA, Xiao L, Pimentel DR, Singh K, and Colucci WS. Role of oxidative stress in myocardial hypertrophy and failure. J Mol Cell Cardiol 34: 379-388, 2002.
126. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 103: 211-225, 2000.
127. Shackelford RE, Heinloth AN, Heard SC, and Paules RS. Cellular and molecular targets of protein S-glutathiolation. Antioxid Redox Signal 7: 940-950, 2005.
128. Solaini G and Harris DA. Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion. Biochem J 390: 377-394, 2005.
129. Sommer D, Coleman S, Swanson SA, and Stemmer PM. Differential susceptibilities of serine/threonine phosphatases to oxidative and nitrosative stress. Arch Biochem Biophys 404: 271-278, 2002.
130. Steinberg SF. Distinctive activation mechanisms and functions for protein kinase Cδ. Biochem J 384: 449-459, 2004.
131. Suematsu N, Tsutsui H, Wen J, Kang D, Ikeuchi M, Ide T, Hayashidani S, Shiomi T, Kubota T, Hamasaki N, and Takeshita A. Oxidative stress mediates tumor necrosis factor-α-induced mitochondrial DNA damage and dysfunction in cardiac myocytes. Circulation 107: 1418-1423, 2002.
132. Sugden PH. Ras, Akt, and mechanotransduction in the cardiac myocyte. Circ Res 93: 1179-1192, 2003.
133. Sugden PH and Clerk A. "Stress-responsive" mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ Res 83: 345-352, 1998.
134. Sumbayev VV and Yasinska IM. Regulation of MAP kinase-dependent apoptotic pathway: implication of reactive oxygen and nitrogen species. Arch Biochem Biophys 436: 406-412, 2005.
135. Takahashi N, Saito Y, Kuwahara K, Harada M, Tanimoto K, Nakagawa Y, Kawakami R, Nakanishi M, Yasuno S, Usami S, Yoshimura A, and Nakao K. Hypertrophic responses to cardiotrophin-1 are not mediated by STAT3, but via a MEK5-ERK5 pathway in cultured cardiomyocytes. J Mol Cell Cardiol 38: 185-192, 2005.
136. Takai Y, Sasaki T, and Matozaki T. Small GTP-binding proteins. Physiol Rev 81: 153-208, 2001.
137. Tanaka K, Honda M, and Takabatake T. Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac myocyte. J Am Coll Cordial 37: 676-685, 2001.
138. Tanno M, Bassi R, Gorog DA, Saurin AT, Jiang J, Heads RJ, Martin JL, Davis RJ, Flavell RA, and Marber MS. Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia. Circ Res 93: 254-261, 2003.
139. Taylor SJ and Shalloway D. Cell cycle-dependent activation of Ras. Curr Biol 6: 1621-1627, 1996.
140. Toufektsian MC, Boucher FR, Tanguy S, Morel S, and de Leiris JG. Cardiac toxicity of singlet oxygen: implication in reperfusion injury. Antioxid Redox Signal 3: 63-69, 2001.
141. Touyz RM, Yao G, Viel E, Amiri F, and Schiffrin EL. Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells. J Hypertens 22: 1141-1149, 2004.
142. Tu VC, Bahl JJ, and Chen QM. Signals of oxidant-induced cardiomyocyte hypertrophy: key activation of p70 S6 kinase-1 and phosphoinositide 3-kinase. J Pharmacol Exp Ther 300: 1101-1110, 2002.
143. Vanhaesebroeck B and Alessi DR. The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 346: 561-576, 2000.
144. Vanhaesebroeck B, Leevers SJ, Ahmadi K, Timms J, Katso R, Driscoll PC, Woscholski R, Parker PJ, and Waterfield MD. Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 70: 535-602, 2001.
145. Watanabe T, Otsu K, Takeda T, Yamaguchi O, Hikoso S, Kashiwase K, Higuchi Y, Taniike M, Nakai A, Matsumara Y, Nishida K, Ichijo H, and Hori M. Apoptosis signal-regulating kinase 1 is involved not only in apoptosis but also in non-apoptotic cardiomyocyte death. Biochem Biophys Res Commun 333: 562-567, 2005.
146. Wellbrock C, Karasarides M, and Marais R. The RAF proteins take centre stage. Nat Rev Mol Cell Biol 5: 875-885, 2004.
147. Wilkins BJ and Molkentin JD. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem Biophys Res Commun 322: 1178-1191, 2004.
148. Winter-Vann AM and Casey PJ. Post-prenylation-processing enzymes as new targets in oncogenesis. Nat Rev Cancer 5: 405-412, 2005.
149. Woo HA, Kang SW, Kim HK, Yang KS, Chae HZ, and Rhee SG. Reversible oxidation of the active site cysteine of peroxiredoxins to cysteine sulphinic acid. Immunoblot detection with antibodies specific for the hyperoxidized cysteine-containing sequence. J Biol Chem 278: 47361-47364, 2003.
150. Woodgett JR. Recent advances in the protein kinase B signaling pathway. Curr Opin Cell Biol 17: 150-157, 2005.
151. Wu S, Gao J, Ohlemeyer C, Roos D, Niessen H, Köttgen E, and Gessner R. Activation of AP-1 through reactive oxygen species by angiotensin 11 in rat cardiomyocytes. Free Radic Biol Med 39: 1601-1610, 2005.
152. Xiao L, Pimentel DR, Wang J, Singh K, Colucci WS, and Sawyer DB. Role of reactive oxygen species and NAD(P)H oxidase in α-adrenoceptor signaling in adult rat cardiac myocytes. Am J Physiol Cell Physiol 282: C926-C934, 2002.
153. Yamamoto M, Yang G, Hong C, Liu J, Holle E, Yu X, Wagner T, Vatner SF, and Sadoshima J. Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy. J Clin Invest 112: 1395-1406, 2003.
154. Zhang GX, Kimura S, Nishiyama A, Shokoji T, Rahman M, and Abe Y. ROS during the acute phase of Ang 11 hypertension participates in cardiovascular MAPK. activation but not vasoconstriction. Hypertension 43: 117-124, 2004.